(Q42541023)

2 November 2017

title

(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease (English)

1 reference

2 November 2017

1 reference

M L Selley

1

1 reference

2 November 2017

publication date

1 July 1998

1 reference

Free Radical Biology and Medicine

2 November 2017

published in

1 reference

2 November 2017

volume

25

1 reference

2 November 2017

issue

2

1 reference

2 November 2017

page(s)

169-174

1 reference

Oxidative stress and the pathogenesis of Parkinson's disease

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Serum lipid peroxides in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Genotoxicity and cytotoxicity of selected pyrrolizidine alkaloids, a possible alkenal metabolite of the alkaloids, and related alkenals.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Cytotoxicity and metabolism of 4-hydroxy-2-nonenal and 2-nonenal in H2O2-resistant cell lines. Do aldehydic by-products of lipid peroxidation contribute to oxidative stress?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Modification of histidine residues in proteins by reaction with 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Determination of the lipid peroxidation product (E)-4-hydroxy-2-nonenal in clinical samples by gas chromatography--negative-ion chemical ionisation mass spectrometry of the O-pentafluorobenzyl oxime.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high-performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionisation mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Cerebrospinal fluid of Parkinson's disease patients inhibits the growth and function of dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Reaction of Glutathione with Conjugated Carbonyls

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2898%2900021-5

7 January 2021

10.1016/S0891-5849(98)00021-5

Identifiers

DOI

1 reference

2 November 2017

1 reference